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Background: Infectious diseases caused by fungi are still a major threat to public health, despite numerous efforts
by researchers. Use of ethnopharmacological knowledge is one attractive way to reduce empiricism and enhance
the probability of success in new drug-finding efforts. In this work, the total alkaloid compounds (AC) from Sida
cordifolia L. (Malvaceae) have been investigated for their free radical scavenging capacity, antifungal and
immunostimulatory properties.
Method: The antifungal activity was investigated against five candida strains using the microplate dilution method
and the Fractional Inhibitory Concentration Index (FICI) of compounds was evaluated. The antioxidant activity of the
samples was evaluate using three separate methods, at last, the immunostimulatory effect on immunosuppressed
wistar rats was performed.
Results: As for the antifungal activity, result varied according to microorganism. The results obtained in this
antifungal activity were interesting and indicated a synergistic effect between alkaloid compounds and the
antifungal references such as Nystatin and Clotrimazole. Antioxidant capacity noticed that the reduction capacity of
DPPH radicals obtained the best result comparatively to the others methods of free radical scavenging. Our results
showed a low immunostimulatory effect and this result could be explained by the lack of biologically active
antioxidants such as polyphenol compounds lowly contained in the alkaloid compounds.
Conclusion: The results of this study showed that alkaloid compounds in combination with antifungal references
(Nystatin and Clotrimazole) exhibited antimicrobial effects against candida strains tested. The results supported the
utilization of these plants in infectious diseases particularly in treatment of candida infections.* Correspondence: ouedraogo_maurice@yahoo.fr
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Diseases due to pathogenic fungi represent a critical
problem to human health and they are one of the main
causes of morbidity and mortality worldwide [1]. The
emergence of pathogens resistant to antibiotics as a re-
sult of their excessive use in clinical and veterinary
applications represents a serious public health concern
[2]. In the last three decades, pathogenic resistant fungi
particularly candida strains, have caused major health
problems throughout the world in women although the
pharmacological industries produced quantities of anti-
biotics. Unfortunately, the resistance of fungi to these
drugs is increasingly important. The search for plants
with antifungal activity has gained increasing importance
in recent years due to the development of resistance. On
the other hand, it is known that free radicals play a fun-
damental role in several diseases. The biochemical
damages caused by free radicals to cells and tissues, lead
to the development of diseases such as arteriosclerosis,
high blood pressure, cancer, inflammation, renal failure,
liver disease [3].
Medicinal plants are largely used either for the preven-
tion, or for the curative treatment of several diseases.
Among the properties behind these virtues, the antioxi-
dant activity holds the first place [4-6]. Plants used in
traditional medicine may constitute an important source
of new biologically active compounds. It is estimated
that there are about 2,500000 species of higher plants
and the majority of these plants have not been studies
for their pharmacological activities [7]. According to
world Health Organization (WHO), 80% of the world
population still relies mainly on substances extract from
plants to cure diseases [8]. The fact that microorganisms
nowadays tend to develop resistance towards drugs,
coupled to the undesirable side effects of certain antibio-
tics offer considerable potential for the development of
new effective antimicrobial and antioxidant agents, me-
dicinal plants are a prolific source. Scientific experiments
on the antimicrobial properties of plant components
were first documented in the late 19th century [9]. The
shortcomings of the drugs available today propel the dis-
covery of new pharmacotherapeutic agents in herbal
medicine [10]. Amongst the medicinal plants investigated
in our research team, the family Malvaceae is largely
represented and some of these plants as Sida cordifolia
L. (Malvaceae). A decoction of this Malvaceae is locally
used in the treatment of coughs, rheumatic and abdom-
inal pain, and diarrhea while the leaf decoction is used in
the treatment of fever and to prevent miscarriage [11].
Some biological activities of these Malvaceae have been
reported [12]. However, to the best of our knowledge,
no information of alkaloid fractions on its antioxidant,
antifungal activities and immunostimulatory capacity
are available.Many fungi are parasite on plants and animals (includ-
ing humans) causing serious diseases in human such as
candidose among others. Furthermore, persons with
immune-deficiencies are particularly susceptible to dis-
eases by candida [13]. Supported especially a reduction
in the immune system due to a lack of antioxidants, this
study was therefore designed to evaluate the possible
beneficial antioxidant, anticandicidal and immunostimu-
latory potencies of the total alkaloid fractions from Sida
cordifolia L. (Malvaceae). Our results would strengthen
the traditional use of this Malvaceae and contribute to
the acceptance of traditional medicine for the best man-
agement of candidoses of which the women suffer much
nowadays.Materials
Plant materials
Sida cordifolia L., was collected in August 2008 in
Gampela, 25 Km east of Ouagadougou, capital of Burkina
Faso. The plant was botanically identified by Prof.
Millogo-Rasolodimby from the plants Biology Department
of the University of Ouagadougou. Voucher specimen was
deposited in the Herbarium of the La.B.E.V. (Laboratory
of Plant Ecology and Biology, UFR/SVT of University of
Ouagadougou) from the University of Ouagadougou.Animals handling
Swiss NMRI mice (25–30 g) and adult albinos Wistar
rats (195–200 g) of both sexes were used for this study.
All animals were housed in cages under controlled con-
ditions of 12-h light/and 12 h without light and 25°C.
They received pellets of food enriched with 20% protein
and water ad libitum. They were deprived of food for
15 h (but with access to drinking water) and weighed be-
fore the experiments. Experiments on the animals were
performed according to the protocols already approved
by the Institute of Health Sciences Research/University
of Ouagadougou (Burkina Faso) and met the inter-
national standards for animal study [14].Test organisms
The studies microorganisms included reference strains
of Candida albicans ATCC 9002, Candida albicans
ATCC 2091, Candida parapsilosis ATCC 22019, Can-
dida tropicalis ATCC 750, Candida Krusei ATCC 6258.
Fungal strains were maintained on agar slant at 4°C
and sub-cultured on a fresh appropriate agar plates 24
h prior to any antifungal activity. Sabouraud Glucose
Agar was used for the activation of fungi. The Mueller
Hinton Broth (MHB) was used for the MIC and MFC
determinations.
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Preparation of extract for acute toxicity study
Fifty grams of powdered plant materials (dried in labora-
tory condition) was extracted with 500 ml of acetone
80% (400 ml acetone + 100 ml water) for 24 h under
mechanic agitation (SM 25 shaker, Edmund BÜHLER,
Germany) at room temperature. After filtration, acetone
was removed under reduced pressure in a rotary evaporator
(BÜCHI, Rotavopor R-200, Switzeland) at approximately
40°C and freeze-dried (Telstar Cryodos 50 freeze-dryer).
The extract was weighed before packing in waterproof plas-
tic flasks and stored at 4°C until use.
Extraction of alkaloid compounds
The harvested plant materials fresh (broken into leaf
stems) were dried in the laboratory at room temperature
(20-25°C), afterwards samples were ground and made al-
kaline and 50 g were used with 28% ammonia and
extracted with chloroform at room temperature for a
total period of 24 h and then the extract was partitioned
between 5% HCl and Chloroform. The aqueous phase
was made alkaline again with ammonia and partitioned
between water and chloroform. Finally chloroform was




Radical scavenging activity of plant fractions against stable
DPPH (2, 2’-diphenyl-1-picrylhydrazyl, Fluka) was deter-
mined with a UV/visible light spectrophotometer (CECIL
CE 2041, CECIL Instruments, England) at 517 nm as
described by [16]. Fraction solutions were prepared by dis-
solving 10 mg of dry extract in 10 ml of methanol. The
samples were homogenized in an ultrasonic bath. 0.5 ml
of aliquots which were prepared at different concentra-
tions from each sample of fraction was mixed with 1 ml of
methanolic DPPH solution (20 mg/ml). After 15 min in
the dark at room temperature, the decrease in absorption
was measured. All experiments were performed in tripli-
cate and expressed in mmol Ascorbic Acid Equivalent per
g of fraction (Y= −16.815x+6.8373; R2 =0.9976). Quercetin
was used as positive control [17,18].
ABTS radical cation decolorization assay
For ABTS radical cation decolorization assay, the proced-
ure followed the method of [16]. ABTS was dissolved in
water to a 7 mM concentration. ABTS radical cation
(ABTS·+) was produced by reacting ABTS stock solution
with 2.45 mM potassium persulfate (final concentration)
and allowing the mixture to stand in the dark at room
temperature for 12 h before use. This mixture was diluted
with ethanol to give an absorbency of 0.7 ± 0.02 units at
734 nm using a UV/visible light spectrophotometer(CECIL CE 2041, CECIL Instruments, England). For our
study, we used 10 μL of the diluted sample (1 mgmL-1 in
methanol) which was allowed to react with 990 μL of fresh
ABTS·+ solution and the absorbance was taken 6 min
exactly after initial mixing. Ascorbic acid was used as
standard (Y= −0.0342x+0.634; R2 = 0.9996) and the cap-
acity of free radical scavenging was expressed as mmol
Ascorbic Acid Equivalent per g of fraction. Quercetin, a
reference compound was used as positive control.
Fe 3+ to Fe 2+ reduction activity (FRAP)
The FRAP assay was performed according to [19].
0.5 mL of each fraction (1 mgmL-1) was mixed with
1.25 mL of phosphate buffer (0.2M, pH 6.6) and 1.25
mL of aqueous potassium hexacyanoferrate [K3Fe(CN)6]
solution (1%). After 30 min incubation at 50°C, 1.25 mL
of trichloroacetic acid (10%) was added and the mixture
was centrifuged at 2000 × g for 10 min. Then, the upper
layer solution (0.625 mL) was mixed with distilled water
(0.625mL) and a freshly prepared FeCl3 solution
(0.125mL, 0.1%). Absorbencies were read at 700 nm on
a UV/visible light spectrophotometer (CECIL CE 2041,
CECIL Instruments, England) and Ascorbic acid was
used to produce the calibration curve (Y= 0.008×-
0.0081; R2 = 0.9999). The iron (Fe3+) reducing activity
determination was performed in triplicate and expressed
in mmol Ascorbic Acid Equivalent per g of fraction.
Troloc, a reference compound was used as positive con-
trol [20].
In vitro antifungal activity
Preparation of inocula
The fungal strains grown on nutrient agar (Muller
Hinton broth) at 35°C for 72 h were suspended in a sa-
line solution (0.9%, w/v) NaCl and adjusted to a turbidity
of 0.5 Mac Farland standard (5×105 CFU/ml) [21].
Preparation of fraction substances
The stock solutions of AC were dissolved in 10%
dimethylsulfoxide (DMSO) in water [21,22] at a final con-
centration of 800 μg/ml. The stock solutions were steri-
lized by filtration through 0.22 μm sterilizing Millipore
express filter.
Minimum inhibitory concentration (MIC) assay
Minimum inhibitory concentration (MIC) was deter-
mined by the microdilution method in culture broth as
recommended by [21,23] with low modifications. 12 ser-
ial two-fold dilutions of AC solutions or conventional
antibiotic were prepared as described before, to obtain
final concentration ranges of 800–0.78125 μg/ml and
50–0.0488 μg/ml for AC and reference substances re-
spectively. The last wells (n°12) served as sterility
controls (contained broth only) or negative control
Ouédraogo et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:33 Page 4 of 10
http://www.ann-clinmicrob.com/content/11/1/33(broth + inoculums). The 96-well micro-plates (NUNC,
Danemark) containing 100 μL of Mueller Hinton (MH)
broth were used. For each fungi strain, three columns of
eleven wells to the micro-plate were used. Each well has
getting: the culture medium + AC solution or Nystatin/
Clotrimazole or the combination of fraction solution
with Nystatin/Clotrimazole + inoculum standardized
at 5×105 CFU/ml (10 μl of inocula) and INT (50 μl;
0.2 mg/ml for 30 min). The plates were sealed with par-
afilm, then agitated with a plate shaker to mix their con-
tents and incubated at 35°C for 48 h. All tests were
performed in triplicate and the fungi activity was
expressed as the mean of inhibitions produced. Viable
microorganisms reduced the yellow dye to a pink colour.
The MIC was defined as the lowest concentration of AC
substance at which no colony was observed after incuba-
tion. So, the MIC was defined as the lowest concentra-
tion where no change was observed, indicating no
growth of microorganism.
Minimum fungicidal concentration (MFC)
Minimum fungicidal concentration (MFC) was deter-
mined by the microdilution method in culture broth as
recommended by [21,23] with low modifications. Mini-
mum fungicidal concentration (MFC) was determined
by adding 50 μl aliquots of the clear wells to 150 μl of
freshly prepared broth medium and incubating at 35°C
for 48 h. The MFC was regarded as the lowest concen-
tration of test sample which did not produced a colour.
All tests were performed in triplicates.
Evaluation of the fractional inhibitory concentration index
of AC
The Muller Hinton agar dilution method was used to
evaluate the Fractional Inhibitory Concentration Index
(FICI) of AC and the tested anti-microbial standard as
reported earlier [24,25]. Eleven (11) serial two-fold dilu-
tions of AC solutions were prepared as described before, to
obtain final concentration range of 800 to 0.78125 μg/ml.
A series of two-fold serial dilutions of Nystatin or Clotri-
mazole was also prepared in the same conditions as AC. In
this way, antifungal standard dilutions were mixed with the
appropriate concentration of AC solution thus obtaining a
series of the combinations of conventional antifungal
and AC solution. The concentrations prepared corre-
sponded to 1-1/1024 of MIC values. The 96-well micro-
plate (NUNC, Danemark) containing 100 μL of Mueller
Hinton (MH) broth were used. For each fungal strain,
three columns of eleven wells to the micro-plate were used.
Each well has getting: the culture medium + combination
of AC solution with Nystatin/Clotrimazole + inoculum
standardized at 5×105 CFU/ml (10 μl of inocula) and INT
(50 μl; 0.2 mg/ml for 30 min). The plates were covered and
incubated at 35°C for 48 h. All tests were performed intriplicate and the fungicidal activity was expressed as the
mean of inhibitions produced. Viable microorganisms
reduced the yellow dye to a pink colour. The analysis of
the combination of AC solution and antifungal references
(Nystatin and Clotrimazole) was obtained by calculating
the Fractional Inhibitory Concentration Index (FICI) as fol-
lows: FICI= (MICa of AC in combination/MICa alone) +
(MICb of the standard antifungal agent in combination/
MICb alone), where MICa (Minimal Inhibitory Concentra-
tion of AC) and MICb (Minimal Inhibitory Concentration
of Nystatin or Clotrimazole). The FICI was interpreted as
follows: (1) a synergistic effect when FICI =0.5; (2) an addi-
tive or indifferent effect when FICI >0.5 and < 1; (3) an an-
tagonistic effect when >1 [21].Immunostimulatory potential of AC on response immune
specific
Acute toxicity study in mice
Healthy male and female Swiss mice (20-30g) were ran-
domly divided into 7 groups (1 control group and 6 trea-
ted assay groups) of 6 animals (3 male and 3 female).
The animals were deprived of food but not water 15 h
prior to the administration of the test suspension. The
control group received intraperitoneally. 10% dimethyl-
sulfoxide (DMSO) solution (in water). The general be-
haviour of the mice was observed at 120 min after the
treatment. The animals were fed with food pellets and
water ad libitum. They were screened for morbidity and
mortality once a day for up 14 days. The number of sur-
vivors after the 14 days period was noted. The toxico-
logical effect was assessed on the basis of mortality,
which was expressed as the median lethal dose (LD50).
The LD50 (Lethal Dose 50 was determined according to
the method of [26].
Animals’ treatment for immunostimulatory potential
The animals were divided into 06 groups of six animals
each one. Groups 1, 2 and 3 were used as controls groups.
Group 1. The rats received 10% DMSO as control by
oral way during 28 days.
Group 2. The rats received cyclosporin A as control
(25 mg/kg, by oral route) during 07 days
(from 1st to 7th day) and then received DMSO
10% (from 8th to 28th day).
Group 3. The rats received concavanalin A
(25 mg/kg, by oral route) from 8th to 28th day
Group 4. The rats received extract of AC from Sida
cordifolia (50 mg/kg bw.)
Group 5. the rats received extract of AC from Sida
cordifolia (100 mg/kg bw.)
Group 6. The rats received extract of AC from Sida
cordifolia (200 mg/kg bw.)
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sporin A (25 mg/kg bw oral route) 1st to 7th day in order
to lower the immune system. The 28th day, the animals
were deprived of water and food during 15 hours [27].
Assessment of immunostimulatory potential
At the end of 28-days period, the animals were deprived
of food for 15 h and blood samples were collected by
cardiac puncture in two tubes for hematological and
serologic parameters analysis. The blood samples
(with heparin and without anticoagulant) were centri-
fuged at 3000 rpm for 5 min to obtain plasma or serum.
Hematological analyses were performed on whole blood,
using automatic counter (Mindray Auto hematology
Analyser BC-5500) to evaluate following parameters:
total white blood cells (TWBC), total lymphocytes using
automatic Counter System (SB FACS) serologic para-
meters (CD8 and CD4) were determined [27].
Statistical analysis
The data of antioxidant and antifungal activities were
expressed as Mean±Standard deviation (SD) of three
determinations. Statistical analysis (ANOVA with a stat-
istical significance level set at p<0.05 and linear regres-
sion) was carried out with XLSTAT 7.1. However, the
data of immunostimulatory effect were expressed as
Mean ± Standard deviation (SD) of six determinations
(n=6). Results were analysed by one-way ANOVA fol-
lowed by Dunnett’s t-test using Prism 4 software. The
level of significance was accepted at p≤0.05.
Results
Free radical scavenging capacity
DPPH radical method
Results are consigned in the (Table 1). The reduction cap-
acity of DPPH radicals was determined by the decrease of
the absorbance induced by antioxidant at 517 nm, which
is induced by antioxidant. The value is 6.63±0.10 mmoL
AAE/g fractions. Control compound gave 13.76±0.26
mmoL AAE/g fraction for Quercetin. The different letters
in the same column of Table 1 indicate significant differ-
ence (P<0.05) for our different fractions.
Fe 3+ to Fe 2+ reduction activity (FRAP)
For FRAP assay, the following value is 3.47±0.01 mmoL
AAE/g fractions. Control compound gave 7.46±3.38 mmoLTable 1 Antioxidant properties of AC from Sida cordifolia




mmoL AAE/g fraction: mmol equivalent Ascorbic Acid for 1g dried fraction.
Values are Mean ±SD (n=3). Different letters in the same column indicate significanAAE/g fractions for Trolox (Table 1). The different letters
in the same column of Table 1 indicate significant differ-
ence (P<0.05) for our different fractions.
ABTS radical cation decolorization assay
For ABTS radical cation decolorization assay, the value
is 3.90±0.03 mmoL AAE/g fractions. The reference com-
pound is Quercetin 7.81±0.21 mmol AAE/g fraction. We
note that, the reduction capacity of DPPH radicals
obtained the best result comparatively to the others
methods of free radical scavenging; but comparatively to
the reference compounds used we notice that the result
is not interesting (Table 1). The different letters in the
same column of Table 1 indicate significant difference
(P<0.05) for our different fractions.
In vitro antifungal activity
Minimum inhibitory concentration (MIC) assay and
Minimum fungicidal concentration (MFC)
As for the Minimum inhibitory concentration assay
(MIC) and Minimum fungicidal concentration (MFC) of
AC and their combination with antifungal references
(Nystatin and Clotrimazole), result varied according to
microorganism and results are summarize in Tables 2, 3
and 4. The MIC values of AC were ranged from 8.33 to
12.5 μg/ml.
Evaluation of the fractional inhibitory concentration index
of fractions
For FICI, our results indicate a synergistic effect be-
tween AC and the antifungal references (Nystatin and
Clotrimazole) (Table 5 and Table 6).
Acute toxicity study in mice
About the acute toxicity study in mice, the value of
LD50 was: 3.4 g/kg. The results of this study indicated
that the extract of Sida cordifolia are low poisonous.
During the 14 day period of acute toxicity evaluation,
some signs of toxicity were observed, but they were all
quickly reversible.
Immunostimulatory potential of AC on response immune
specific
At last, concerning the effect of alkaloid fractions on
specific immune response, Figure 1 shows the effects of




t difference (P<0.05) for AC.
Table 2 Minimal Inhibitory Concentration (MIC) of AC from Sida cordifolia L., and antifungal references (Nystatin and
Clotrimazole)
Microorganisms MIC (μg/ml) AC of Sida cordifolia MIC (μg/ml) Nystatin MIC(μg/ml) Clotrimazole
Candida albicans ATCC 9002 10.42±3.61b 4.17±1.80 4.17±1.80
Candida albicans ATCC 2091 8.33±3.61b 4.17±1.80 6.25±0.00
Candida parapsilosis ATCC 22019 12.5±0.00a 6.25±0.00 6.25±0.00
Candida krusei ATCC 6258 8.33±3.61c 4.17±1.80 4.17±1.80
Candida tropicalis ATCC 750 10.42±3.61b 4.17±1.80 6.25±0.00
Values are Mean ±SD (n=3). Different letters in the same column indicate significant difference (P<0.05) for AC.
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the total alkaloid fractions concentrations of 50 mg/kg,
100 mg/kg and 200 mg/kg bw involved a significant de-
crease of hematologic and serologic parameters (p<0.01)
compared to the group controls. On hematological and
serological parameters (Figure 1), there is actual evi-
dence that cyclosporin A has an immunosuppressive po-
tential and concavanalin A has an immunostimulatory
property. The low increase in hematological and sero-
logical parameters of the test group 6, compared to the
control group 2 (cyclosporin A control) allows to say
that the total alkaloid fractions (200 mg/kg bw; p<0.01)
has a low immunostimulatory effect.
Discussion
Infectious diseases caused by fungi are still a major
threat to public health, despite numerous efforts by
researchers. Their impact is particularly large in develop-
ing countries due to the relative unavailability of medi-
cines and the emergence of widespread drug resistance
[28]. Use of ethnopharmacological knowledge is one at-
tractive way to reduce empiricism and enhance the
probability of success in new drug-finding efforts [29].
Validation and selection of primary screening assays are
pivotal to guarantee sound selection of extracts or mole-
cules with relevant pharmacological action and worthy
following up [30]. The number of multi-drug resistant
microbial strains and the appearance of strains with
reduced susceptibility to antibiotics are continuously
increasing. This increase has been attributed to indis-
criminate use of broad-spectrum, immunosuppressiveTable 3 Minimal Fungicidal Concentration (MFC) of AC from S
Clotrimazole)
Microorganisms MFC (μg/ml)
AC of Sida cordifo
Candida albicans ATCC 9002 33.33±14.43b
Candida albicans ATCC 2091 29.17±19.09c
Candida parapsilosis ATCC 22019 41.67±14.43a
Candida krusei ATCC 6258 29.17±19.09c
Candida tropicalis ATCC 750 33.33±14.43b
Values are Mean ±SD (n=3). Different letters in the same column indicate significanagent and ongoing epidemics of HIV infection [31]. The
development of drug resistance in human pathogens
against commonly used antibiotics and antifungal has
necessitated a search for new antimicrobial substances.
Higher plants produce diverse secondary metabolites
with different biological activities. These natural com-
pounds may be a source of compounds with antimicro-
bial effects and therefore possible candidates for the
development of new antifungal agents [32,33].
On the toxicity of the extract, according to [34],
pharmacological substances whole LD50 is less than
5 mg/kg body weight are classified in the range of highly
toxic substances, those with a LD50 between 5 mg/kg
body weight and 5000 mg/kg body weight are classified
in the range of moderately toxic substances and those
with the lethal dose is more than 5000 mg/kg body
weight not toxic. In this fact, if we refer to this classifica-
tion we could say that the extract of Sida cordifolia is
moderately toxic and would be regarded as being safe or
of low toxicity [35].
For the antioxidants properties, we have tested three
methods for a best appreciation of our results; because a
recent study demonstrates that there are differences be-
tween the test systems for the determination of the anti-
oxidants properties [36]. The phytochemical analysis
carried out on Sida cordifolia L., extract show that sev-
eral polyphenol including flavonoids are found in its
extracts [11]. Generally, the chemical structure of flavan-
3-ol family has good antioxidants response towards
DPPH* radical. The hydrogen donating substituents
(hydroxyl groups), attached to aromatic ring structuresida cordifolia L., and antifungal references (Nystatin and







t difference (P<0.05) for AC.
Table 4 Minimal Inhibitory Concentration (MIC) of combination of AC from Sida cordifolia L. and antifungal references
(Nystatin and Clotrimazole)
Microorganisms MIC (μg/ml) combination of AC + Nystatin MIC (μg/ml) combination of AC + Clotrimazole
Candida albicans ATCC 9002 1.30±0.45a 1.30±0.45b
Candida albicans ATCC 2091 1.04±0.45b 1.30±0.45b
C. parapsilosis ATCC 22019 1.30±0.45a 1.56±0.00a
C. krusei ATCC 6258 1.04±0.45b 1.30±0.45b
C. tropicalis ATCC 750 1.04±0.45b 1.56±0.00a
Values are Mean ±SD (n=3). Different letters in the same column indicate significant difference (P<0.05) for AC.
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redox reaction that helps them to scavenge the free radi-
cals [37]. So, it can be observed that the content of
polyphenolic compounds of Sida cordifolia could be re-
sponsible for the radical scavenging activity. Thus, the
restoration of the antioxidant defense system in this
study may be due in part to the antioxidant activity of
polyphenolic compounds [38]. In effect, the amount of
DPPH scavenging activity in the majority of the plant
extracts is attributed to the phenolic fraction [39]. In the
present study, the scavenging of the DPPH radical may
be attributed to its hydrogen-donating ability. Earlier
workers have observed a direct correlation between anti-
oxidant activity and the reducing power of certain plant
extracts [40]. Certainly, the reducing property is gener-
ally associated with the presence of reductones, which
exert antioxidant action by breaking the free radical
chain by donating a hydrogen atom [40].
The results obtained in this study about antifungal activ-
ity indicate a considerable difference in antifungal activity
of alkaloid compounds and in combination with antifungal
references. About these findings, it is widely known that
plants possess healing properties [41]. The best of our
knowledge, this is the first report dealing with the inter-
action between alkaloid compounds with the chemical
antimicrobial drugs currently in use. Synergy research in
phytomedicine has established as a new key activity in re-
cent years. It is one main aim of this research to find a sci-
entific rational for the therapeutic superiority of herbalTable 5 Fractional Inhibitory Concentration (FIC) and FICI
of combination of AC from Sida cordifolia L. with Nystatin
Microorganisms FICa FICb FICI Effect
C. albicans ATCC 9002 0.12 0.31 0.43 Synergistic
C. albicans ATCC 2091 0.12 0.25 0.37 Synergistic
C. parapsilosis ATCC 22019 0.10 0.21 0.31 Synergistic
C. krusei ATCC 6258 0.12 0.25 0.37 Synergistic
C. tropicalis ATCC 750 0.10 0.25 0.35 Synergistic
FICa = MIC of AC in combination/MICa alone; FICb = MIC of the antifungal
agent in combination/ MICb alone and FICI= FICa + FICb.
a= alkaloid compounds; b= Nystatin.
The FICI was interpreted as follows: (1) a synergistic effect when FICI =0.5; (2)
an additive or indifferent effect when FICI >0.5 and <1; (3) an antagonistic
effect when >1.drugs derived from traditional medicine as compared with
single constituents thereof. Synergy effects of the mixture
of bioactive constituents and their byproducts contained
in plant extracts are claimed to be responsible for the
improved effectiveness of many extracts and conventional
antimicrobial drugs [42]. Such properties can be partly
attributed to the diverse array of secondary metabolite
such as alkaloids which are known to be essential for
plants’ defense against microbial attack or insect and ani-
mal predation [43]. Moreover, it is important to notice
that over compounds such as alkaloids have strong anti-
microbial activities [15]. Alkaloid compounds were very
susceptible fungus probably because they act on mucopo-
lysacharide capsule of fungal strains. In effect, the polysac-
charide capsular material in some of the pathogenic
microorganism is responsible for virulence and antimicro-
bial resistance [44]. It is the reason of difference in
antifungal activity of alkaloid compounds and their com-
bination with antifungal references. Recent studies showed
that the alkaloids are known to have antimicrobial proper-
ties and [45] have reported about 300 alkaloids showing
such activity.
As for the immunostimulatory capacity, results could be
explained by the lack of biologically active antioxidants
such as polyphenol compounds lowly contained in the al-
kaloid compounds. In effect, polyphenol compounds are
considered as the major contributors to the antioxidant po-
tential of plants [46], and antioxidant play an important roleTable 6 Fractional inhibitory concentration (FIC) and FICI
of combination of n-butanol fraction from Sida cordifolia
L. with Clotrimazole
Microorganisms FICa FICb FICI Effect
C. albicans ATCC 9002 0.12 0.31 0.43 Synergistic
C. albicans ATCC 2091 0.12 0.21 0.33 Synergistic
C. parapsilosis ATCC 22019 0.10 0.25 0.35 Synergistic
C. krusei ATCC 6258 0.12 0.31 0.43 Synergistic
C. tropicalis ATCC 750 0.10 0.25 0.35 Synergistic
FICa = MICa alone /MIC of AC in combination; FICb = MICb of standard antifungal
agent/MIC of the antifungal agent in combination and FICI= FICa + FICb.
a= alkaloid compounds; b= Clotrimazole.
The FICI was interpreted as follows: (1) a synergistic effect when FICI =0.5; (2)
an additive or indifferent effect when FICI >0.5 and <1; (3) an antagonistic
effect when >1.
Figure 1 Effects of AC from Sida cordifolia L. on hematological and serological parameters in wistar rats. TWBC (103/μl); Lym= Total
Lymphocytes. Values are mean ± S.E.M. (n=6) one-way ANOVA followed by Dunnett’s t- test: Compare all vs. control: **++ ¥¥ p<0.01 compared with
control groups (DMSO 10%, Cyclosporin A and Concavanalin A). Group 1: rats received 10% DMSO during 28 days. Group 2: rats received cyclosporin A
(25 mg/kg bw.) from 1st to the 7th day and 10% DMSO from 8th to the 28th day. Group 3: rats received cyclosporin A (25 mg/kg bw.) from 1st to the 7th
day and received Concavanalin A (25 mg/kg bw.) dissolved in 10% DMSO from the 8th day to the 28th day. Group 4: rats received cyclosporin A
(25 mg/kg bw.) from 1st to the 7th day and received AC from Sida cordifolia (50 mg/kg bw.) dissolved in 10% DMSO from the 8th day to the 28th day.
Group 5: rats received cyclosporin A (25 mg/kg bw.) from 1st to the 7th day and received AC from Sida cordifolia (100 mg/kg bw.) dissolved in 10%
DMSO from the 8th day to the 28th day. Group 6: rats received cyclosporin A (25 mg/kg bw.) from 1st to the 7th day and received AC from Sida
cordifolia (200 mg/kg bw.) dissolved in 10% DMSO from the 8th day to the 28th day.
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http://www.ann-clinmicrob.com/content/11/1/33in controlling oxidative stress and decreasing disease activ-
ity [47]. This relation could be responsible for reducing
oxidative stress due to cyclosporin A. These biological anti-
oxidants by inhibiting the action of cyclosporin A have an
inhibitory effect on the highly specific T helper response,
eliminating the primary cell response to antigen. Indeed,
after binding to an intra-cytoplasmic cyclophilin receptor, it
blocks the activation pathway and calcineurin-dependent
transcription and consequently gene expression of cyto-
kines required for immune response [48]. In this case, the
low immunostimulatory effect observed is due by the
action of alkaloid compounds which are not the bioactive
antioxidant compounds being able inhibit the oxidative
stress. Indeed, surely this low immune power could be alsoexplained by the low bioavailability of the extracts adminis-
tered orally. It is worth noting that the intestinal absorption
of plant extracts through the intestinal absorption is often
low and weak [49].
Conclusion
In conclusion, the screening of antioxidant, antifungal
and immunostimulatory activities performed on alkal-
oid compounds from Sida cordifolia L. which was trad-
itionally used as herbs shows that they are endowed
with potentially exploitable antifungal activity. Further
purification of the active compounds and their antican-
dicidal activity evaluation are therefore suggested for
further studies.
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